Matthew Harris
Vermogen: 25 M $ op 30-06-2026
Vermogen: 25 M $ op 30-06-2026
Matthew Harris is the founder and the Chief Scientific Officer of Clarity Pharmaceuticals Ltd., a company founded in 2010.
He was previously the Chief Executive Officer of Gateway Capital Ltd. and a Non-Executive Director at Genera Biosystems Ltd. from 2007 to 2008.
Dr. Harris holds a doctorate from The Australian National University and an MBA from the Australian Graduate School of Management.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 22-08-2025 | 16.699.842 ( 4,48% ) | 25 M $ | 30-06-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| CLARITY PHARMACEUTICALS LTD | Oprichter | 01-01-2010 |
| Bedrijven | Functie | Einde |
|---|---|---|
| GENERA BIOSYSTEMS LIMITED | Directeur/Bestuurslid | 12-12-2008 |
Gateway Capital Ltd.
Gateway Capital Ltd. Financial ConglomeratesFinance Investment firm | President | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 5 |
|---|---|
Australian National University
Australian National University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Gateway Capital Ltd.
Gateway Capital Ltd. Financial ConglomeratesFinance Investment firm | Finance |
Genera Biosystems Ltd.
Genera Biosystems Ltd. Medical SpecialtiesHealth Technology Manufactures, develops and commercializes multiplexed molecular diagnostic tests | Health Technology |
Australian Graduate School of Management
Australian Graduate School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Clarity Pharmaceuticals Ltd.
Clarity Pharmaceuticals Ltd. Medical SpecialtiesHealth Technology Develops radiopharmaceutical products | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau